Drug Metabolism Reviews

Papers
(The median citation count of Drug Metabolism Reviews is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Biotransformation research advances – 2022 year in review41
Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special population33
Introduction to the mini special issue on next generation drug discovery and development: rethinking translational pharmacology for accelerated drug development32
International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019–2020 concluding remarks26
Cutting-edge strategies and critical advancements in characterization and quantification of metabolites concerning translational metabolomics24
Metabolism of m -CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects23
GSTM1 and GSTT1 polymorphisms in healthy volunteers – a worldwide systematic review19
Molecular docking to investigate HLA-associated idiosyncratic drug reactions19
Promising role of peroxisome proliferator-activated receptors in respiratory disorders, a review19
Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions18
Deoxynivalenol and its modified forms: key enzymes, inter-individual and interspecies differences in metabolism15
The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy14
Biopolymers as promising vehicles for drug delivery to the brain13
Biotransformation research advances – 2023 year in review13
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms13
The annoying flaws of gerontological research13
Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice12
Pregnane X receptor as a therapeutic target for cholestatic liver injury11
Ocular drug-metabolizing enzymes: focus on esterases11
Molecular mechanisms of hepatotoxicity induced by compounds occurring in Evodiae Fructus10
The role and current research status of resveratrol in the treatment of osteoarthritis and its mechanisms: a narrative review10
Clinical pharmacokinetics of nebivolol: a systematic review10
Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic9
Investigating the association between CYP2J2 inhibitors and QT prolongation: a literature review9
Scaling factors to inform in vitro - in vivo extrapolation from preclinical and livestock animals: state of the field and recommendations 8
A transcriptional regulatory network of HNF4α and HNF1α involved in human diseases and drug metabolism8
Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: insights into the mechanisms implicated in the hepatic toxicity8
The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure7
Transporter-mediated drug–drug interactions: advancement in models, analytical tools, and regulatory perspective7
Herb-drug interaction potential of Astragali Radix : a metabolic perspective6
Drug metabolism and transport mediated the hepatotoxicity of Pleuropterus multiflorus root: a review6
Bioactivation and reactivity research advances – 2022 year in review‡5
Cell-Biomaterial constructs for wound healing and skin regeneration5
The aminosalicylate - folate connection5
Drug transporters in drug disposition – highlights from the year 20234
Pharmacogenomics in the era of next generation sequencing – from byte to bedside4
3D self-assembled nanocarriers for drug delivery4
Novel insights in drug transporter sciences: the year 2021 in review4
Physiological and pathophysiological roles of hepoxilins and their analogs4
Melatonin in cancer biology: pathways, derivatives, and the promise of targeted delivery4
Drug transporters in drug disposition – the year 2022 in review4
Recent advances in drug transporter sciences: highlights from the year 20204
Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy4
Metabolism and detection of designer benzodiazepines: a systematic review3
Effects of cannabidiol and Δ 9 -tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review3
Targeting endothelial cell metabolism in cancerous microenvironment: a new approach for anti-angiogenic therapy3
Prediction of drug-induced kidney injury in drug discovery3
Bioanalytical strategies in drug discovery and development3
Recent developments inin vitroandin vivomodels for improved translation of preclinical pharmacokinetics and pharmacodynamics data3
Bioactivation and reactivity research advances – 2023 year in review3
Novel advances in biotransformation and bioactivation research – 2020 year in review3
New strategy for rational use of antihypertensive drugs in clinical practice in high-altitude hypoxic environments3
0.026437997817993